Robert L. Coleman

United States

Research Interests

Explore related searches

Professors in United States Professors in Cancer Biology Cancer Biology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (7)

Iain McNeish

Imperial College London

UNITED KINGDOM

View details

Rebecca S. Kristeleit

University of Arizona College of Medicine

UNITED STATES

View details

Jonathan Ledermann

University College London

UNITED KINGDOM

View details

Kevin Lin

Head of Translational Medicine

Revolution Medicines

UNITED STATES

View details

Susana Banerjee

Reader in Women's Cancers (Systemic Therapy and Clinical Trials)

Institute of Cancer Research

UNITED KINGDOM

View details

Mansoor Mirza

Chief Oncologist

Rigshospitalet

DENMARK

View details

Antonio González-Martín

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Robert L. Coleman

Research Interests

Explore related searches

Contact this professor

Articles (11)

Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib versus Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer

Reply to C. Marchetti et al

Evaluating open access publication and research impact in gynecologic oncology

Reply to Z.R. McCaw et al

Systemic therapy de-escalation in advanced ovarian cancer: a new era on the horizon?

Can fluorescence-guided surgery improve optimal surgical treatment for ovarian cancer? A systematic scoping review of clinical studies

PARP inhibitor era: current status and future directions

Safety and activity of anti-mesothelin antibody–drug conjugate anetumab ravtansine in combination with pegylated-liposomal doxorubicin in platinum-resistant ovarian cancer: multicenter, phase Ib dose escalation and expansion study

Biomarker-driven therapy in endometrial cancer

Integrating antibody drug conjugates in the management of gynecologic cancers

Novel therapies leading to a new landscape in gynecologic tumors

Collaborators (7)

Iain McNeish

Rebecca S. Kristeleit

Jonathan Ledermann

Kevin Lin

Susana Banerjee

Mansoor Mirza

Antonio González-Martín

Make your next move.